top of page
Company News
Connect with us at BIO Digital 2021!
KLUS Pharma is Attending BIO Partnering at JPM
December 5th, 2020
KLUS Pharma will attend BIO Partnering at JPM Digital Event held on January 11-15, 2021.
Looking for Partnerships to Combat COVID-19
June 1st, 2020
We are looking for partnerships to develop and distribute ACV200-17, a peptide drug to prevent COVID-19, in affected countries.
IND for KL-A289 is Approved in China
September 2nd, 2020
The IND for KL-A289, an anti-LAG-3 monoclonal antibody, was recently approved by the NMPA in China.
KLUS Pharma to Present at BIO Digital
May 7th, 2020
KLUS Pharma will present an update for SKB264, a novel TROP2 ADC undergoing a Phase 1/2 clinical trial.
KLUS Pharma to Present at ASCO Annual Meeting
April 25th, 2020
KLUS Pharma will present clinical updates for our HER2 and TROP2 ADC programs at ASCO held on May 29-31, 2020.
bottom of page